Valuation: Lead Data Inc.

Market Cap 539M 16.65M 14.63M 13.6M 12.48M 23.45M 1.6B 23.81M 162M 63.11M 788M 62.52M 61.17M 2.73B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.55M 15.42M 14.34M 13.16M 24.72M 1.69B 25.1M 170M 66.52M 831M 65.9M 64.48M 2.87B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+3.48% 16.65M
+1.11%-2.68%+19.61%+6.65% 9.74B
+1.27%+1.94%+14.96%+5.12% 1.35B
-6.34%-9.05% - - 1.25B
+0.93%-1.53%+1.68%-10.90% 1.06B
-2.70%-5.72%+34.25%+16.69% 571M
-3.33%-6.54%-28.09%-55.10% 561M
+0.57%+0.28%-11.69%-10.79% 413M
+1.01%-8.17%+91.55%+134.29% 379M
+0.32%-9.51%-60.15%-83.60% 240M
Average -1.70%-6.23%+6.90%+0.65% 1.56B
Weighted average by Cap. +0.17%-3.28%+16.19%+4.54%

Financials

2024 2025
Net sales 15.47M 478K 420K 390K 358K 673K 46.04M 684K 4.64M 1.81M 22.63M 1.79M 1.76M 78.26M 111M 3.42M 3.01M 2.79M 2.56M 4.82M 329M 4.89M 33.19M 12.97M 162M 12.84M 12.57M 560M
Net income -134M -4.14M -3.63M -3.38M -3.1M -5.82M -398M -5.91M -40.11M -15.67M -196M -15.53M -15.19M -677M -44.02M -1.36M -1.2M -1.11M -1.02M -1.92M -131M -1.95M -13.2M -5.16M -64.42M -5.11M -5M -223M
Net Debt -16.95M -524K -460K -428K -393K -738K -50.47M -749K -5.08M -1.99M -24.81M -1.97M -1.92M -85.78M 29.12M 900K 791K 735K 675K 1.27M 86.68M 1.29M 8.73M 3.41M 42.62M 3.38M 3.31M 147M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock